{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:50:18Z","timestamp":1792018218765,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41590-018-0185-0","type":"journal-article","created":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T08:10:53Z","timestamp":1534320653000},"page":"954-962","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":152,"title":["Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6994-2595","authenticated-orcid":false,"given":"Linda","family":"Quatrini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Wieduwild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Escaliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Filtjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Chasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Laprie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7022-8287","authenticated-orcid":false,"given":"Eric","family":"Vivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4041-0103","authenticated-orcid":false,"given":"Sophie","family":"Ugolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"key":"185_CR1","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1126\/science.1214935","volume":"335","author":"R Medzhitov","year":"2012","unstructured":"Medzhitov, R., Schneider, D. S. & Soares, M. P. Disease tolerance as a defense strategy. Science 335, 936\u2013941 (2012).","journal-title":"Science"},{"key":"185_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1146\/annurev.immunol.20.082401.104914","volume":"20","author":"JI Webster","year":"2002","unstructured":"Webster, J. I., Tonelli, L. & Sternberg, E. M. Neuroendocrine regulation of immunity. Annu. Rev. Immunol. 20, 125\u2013163 (2002).","journal-title":"Annu. Rev. Immunol."},{"key":"185_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nri3042","volume":"11","author":"MR Irwin","year":"2011","unstructured":"Irwin, M. R. & Cole, S. W. Reciprocal regulation of the neural and innate immune systems. Nat. Rev. Immunol. 11, 625\u2013632 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"185_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri.2017.1","volume":"17","author":"DW Cain","year":"2017","unstructured":"Cain, D. W. & Cidlowski, J. A. Immune regulation by glucocorticoids. Nat. Rev. Immunol. 17, 233\u2013247 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"185_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrm.2016.152","volume":"18","author":"ER Weikum","year":"2017","unstructured":"Weikum, E. R., Knuesel, M. T., Ortlund, E. A. & Yamamoto, K. R. Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat. Rev. Mol. Cell Biol. 18, 159\u2013174 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"185_CR6","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1084\/jem.20171048","volume":"214","author":"L Quatrini","year":"2017","unstructured":"Quatrini, L. et al. Host resistance to endotoxic shock requires the neuroendocrine regulation of group 1 innate lymphoid cells. J. Exp. Med. 214, 3531\u20133541 (2017).","journal-title":"J. Exp. Med."},{"key":"185_CR7","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1182\/blood-2006-10-048215","volume":"109","author":"S Bhattacharyya","year":"2007","unstructured":"Bhattacharyya, S., Brown, D. E., Brewer, J. A., Vogt, S. K. & Muglia, L. J. Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109, 4313\u20134319 (2007).","journal-title":"Blood"},{"key":"185_CR8","doi-asserted-by":"publisher","first-page":"e1002269","DOI":"10.1371\/journal.pbio.1002269","volume":"13","author":"CC Li","year":"2015","unstructured":"Li, C. C., Munitic, I., Mittelstadt, P. R., Castro, E. & Ashwell, J. D. Suppression of dendritic cell-derived IL-12 by endogenous glucocorticoids is protective in LPS-induced sepsis. PLoS Biol. 13, e1002269 (2015).","journal-title":"PLoS Biol."},{"key":"185_CR9","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1096\/fj.11-192112","volume":"26","author":"A Kleiman","year":"2012","unstructured":"Kleiman, A. et al. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J. 26, 722\u2013729 (2012).","journal-title":"FASEB J."},{"key":"185_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.chom.2010.01.010","volume":"7","author":"AM Jamieson","year":"2010","unstructured":"Jamieson, A. M., Yu, S., Annicelli, C. H. & Medzhitov, R. Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection. Cell Host Microbe 7, 103\u2013114 (2010).","journal-title":"Cell Host Microbe"},{"key":"185_CR11","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1084\/jem.185.7.1185","volume":"185","author":"MC Ruzek","year":"1997","unstructured":"Ruzek, M. C., Miller, A. H., Opal, S. M., Pearce, B. D. & Biron, C. A. Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J. Exp. Med. 185, 1185\u20131192 (1997).","journal-title":"J. Exp. Med."},{"key":"185_CR12","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.4049\/jimmunol.162.6.3527","volume":"162","author":"MC Ruzek","year":"1999","unstructured":"Ruzek, M. C., Pearce, B. D., Miller, A. H. & Biron, C. A. Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection. J. Immunol. 162, 3527\u20133533 (1999).","journal-title":"J. Immunol."},{"key":"185_CR13","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen, T. & Cidlowski, J. A. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N. Engl. J. Med. 353, 1711\u20131723 (2005).","journal-title":"N. Engl. J. Med."},{"key":"185_CR14","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.4049\/jimmunol.156.12.4746","volume":"156","author":"JS Orange","year":"1996","unstructured":"Orange, J. S. & Biron, C. A. Characterization of early IL-12, IFN-\u03b1\u03b2, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156, 4746\u20134756 (1996).","journal-title":"J. Immunol."},{"key":"185_CR15","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.4049\/jimmunol.156.3.1138","volume":"156","author":"JS Orange","year":"1996","unstructured":"Orange, J. S. & Biron, C. A. An absolute and restricted requirement for IL-12 in natural killer cell IFN-? production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156, 1138\u20131142 (1996).","journal-title":"J. Immunol."},{"key":"185_CR16","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2017.09.052","volume":"171","author":"OE Weizman","year":"2017","unstructured":"Weizman, O. E. et al. ILC1 confer early host protection at initial sites of viral infection. Cell 171, 795\u2013808 (2017).","journal-title":"Cell"},{"key":"185_CR17","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.micinf.2003.09.007","volume":"5","author":"A Krmpotic","year":"2003","unstructured":"Krmpotic, A., Bubic, I., Polic, B., Lucin, P. & Jonjic, S. Pathogenesis of murine cytomegalovirus infection. Microbes Infect. 5, 1263\u20131277 (2003).","journal-title":"Microbes Infect."},{"key":"185_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/JVI.79.1.661-667.2005","volume":"79","author":"J Loh","year":"2005","unstructured":"Loh, J., Chu, D. T., O'Guin, A. K., Yokoyama, W. M. & Virgin, H. W. Natural killer cells utilize both perforin and ? interferon to regulate murine cytomegalovirus infection in the spleen and liver. J. Virol. 79, 661\u2013667 (2005).","journal-title":"J. Virol."},{"key":"185_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00430-015-0412-3","volume":"204","author":"CA Biron","year":"2015","unstructured":"Biron, C. A. & Tarrio, M. L. Immunoregulatory cytokine networks: 60 years of learning from murine cytomegalovirus. Med. Microbiol. Immunol. (Berl.) 204, 345\u2013354 (2015).","journal-title":"Med. Microbiol. Immunol. (Berl.)"},{"key":"185_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/12703","volume":"23","author":"F Tronche","year":"1999","unstructured":"Tronche, F. et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23, 99\u2013103 (1999).","journal-title":"Nat. Genet."},{"key":"185_CR21","doi-asserted-by":"publisher","first-page":"18324","DOI":"10.1073\/pnas.1112064108","volume":"108","author":"E Narni-Mancinelli","year":"2011","unstructured":"Narni-Mancinelli, E. et al. Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc. Natl. Acad. Sci. USA 108, 18324\u201318329 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"185_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","volume":"13","author":"H Spits","year":"2013","unstructured":"Spits, H. et al. Innate lymphoid cells--a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145\u2013149 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"185_CR23","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1096\/fj.09-134684","volume":"23","author":"E Ayroldi","year":"2009","unstructured":"Ayroldi, E. & Riccardi, C. Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J. 23, 3649\u20133658 (2009).","journal-title":"FASEB J."},{"key":"185_CR24","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1182\/blood-2004-03-0920","volume":"104","author":"DV Delfino","year":"2004","unstructured":"Delfino, D. V., Agostini, M., Spinicelli, S., Vito, P. & Riccardi, C. Decrease of Bcl-xL and augmentation of thymocyte apoptosis in GILZ overexpressing transgenic mice. Blood 104, 4134\u20134141 (2004).","journal-title":"Blood"},{"key":"185_CR25","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/sj.cdd.4401456","volume":"11","author":"S Schmidt","year":"2004","unstructured":"Schmidt, S. et al. Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ. 11, S45\u2013S55 (2004).","journal-title":"Cell Death Differ."},{"key":"185_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nri.2017.108","volume":"18","author":"AH Sharpe","year":"2017","unstructured":"Sharpe, A. H. & Pauken, K. E. The diverse functions of the PD1 inhibitory pathway. Nat. Rev. Immunol. 18, 153\u2013167 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"185_CR27","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1126\/science.1070884","volume":"296","author":"H Arase","year":"2002","unstructured":"Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B. & Lanier, L. L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323\u20131326 (2002).","journal-title":"Science"},{"key":"185_CR28","doi-asserted-by":"publisher","first-page":"e1001347","DOI":"10.1371\/journal.ppat.1001347","volume":"7","author":"Y Chen","year":"2011","unstructured":"Chen, Y. et al. Programmed death (PD)-1-deficient mice are extremely sensitive to murine hepatitis virus strain-3 (MHV-3) infection. PLoS Pathog. 7, e1001347 (2011).","journal-title":"PLoS Pathog."},{"key":"185_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0065-2776(08)60389-2","volume":"70","author":"H Okamura","year":"1998","unstructured":"Okamura, H., Tsutsui, H., Kashiwamura, S., Yoshimoto, T. & Nakanishi, K. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70, 281\u2013312 (1998).","journal-title":"Adv. Immunol."},{"key":"185_CR30","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.4049\/jimmunol.165.9.4787","volume":"165","author":"GC Pien","year":"2000","unstructured":"Pien, G. C., Satoskar, A. R., Takeda, K., Akira, S. & Biron, C. A. Cutting edge: selective IL-18 requirements for induction of compartmental IFN-\u03b3 responses during viral infection. J. Immunol. 165, 4787\u20134791 (2000).","journal-title":"J. Immunol."},{"key":"185_CR31","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1084\/jem.20121015","volume":"209","author":"H Frebel","year":"2012","unstructured":"Frebel, H. et al. Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. J. Exp. Med. 209, 2485\u20132499 (2012).","journal-title":"J. Exp. Med."},{"key":"185_CR32","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1172\/JCI62860","volume":"122","author":"JJ Erickson","year":"2012","unstructured":"Erickson, J. J. et al. Viral acute lower respiratory infections impair CD8+ T cells through PD-1. J. Clin. Invest. 122, 2967\u20132982 (2012).","journal-title":"J. Clin. Invest."},{"key":"185_CR33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/JVI.71.1.267-275.1997","volume":"71","author":"CH Tay","year":"1997","unstructured":"Tay, C. H. & Welsh, R. M. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71, 267\u2013275 (1997).","journal-title":"J. Virol."},{"key":"185_CR34","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1084\/jem.182.4.1045","volume":"182","author":"JS Orange","year":"1995","unstructured":"Orange, J. S., Wang, B., Terhorst, C. & Biron, C. A. Requirement for natural killer cell-produced interferon \u03b3 in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182, 1045\u20131056 (1995).","journal-title":"J. Exp. Med."},{"key":"185_CR35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fimmu.2016.00351","volume":"7","author":"M Chiesa Della","year":"2016","unstructured":"Della Chiesa, M. et al. Features of memory-like and PD-1+ human NK cell subsets. Front. Immunol. 7, 351 (2016).","journal-title":"Front. Immunol."},{"key":"185_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1089\/vim.2011.0096","volume":"25","author":"S Norris","year":"2012","unstructured":"Norris, S. et al. PD-1 expression on natural killer cells and CD8+ T cells during chronic HIV-1 infection. Viral Immunol. 25, 329\u2013332 (2012).","journal-title":"Viral Immunol."},{"key":"185_CR37","doi-asserted-by":"publisher","first-page":"72961","DOI":"10.18632\/oncotarget.12150","volume":"7","author":"A Beldi-Ferchiou","year":"2016","unstructured":"Beldi-Ferchiou, A. et al. PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma. Oncotarget 7, 72961\u201372977 (2016).","journal-title":"Oncotarget"},{"key":"185_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nri1571","volume":"5","author":"R Glaser","year":"2005","unstructured":"Glaser, R. & Kiecolt-Glaser, J. K. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 5, 243\u2013251 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"185_CR39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","volume":"161","author":"P Sharma","year":"2015","unstructured":"Sharma, P. & Allison, J. P. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 161, 205\u2013214 (2015).","journal-title":"Cell"},{"key":"185_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","volume":"348","author":"P Sharma","year":"2015","unstructured":"Sharma, P. & Allison, J. P. The future of immune checkpoint therapy. Science 348, 56\u201361 (2015).","journal-title":"Science"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41590-018-0185-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41590-018-0185-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41590-018-0185-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T06:42:08Z","timestamp":1693809728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-018-0185-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1038\/s41590-018-0185-0","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,20]]},"assertion":[{"value":"8 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.V. is a cofounder and employee of Innate Pharma.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}